Literature DB >> 25542425

Pharmacologic inhibition of small-conductance calcium-activated potassium (SK) channels by NS8593 reveals atrial antiarrhythmic potential in horses.

Maria Mathilde Haugaard1, Eva Zander Hesselkilde2, Steen Pehrson3, Helena Carstensen2, Mette Flethøj2, Kirstine Færgemand Præstegaard2, Ulrik Svane Sørensen4, Jonas Goldin Diness4, Morten Grunnet4, Rikke Buhl2, Thomas Jespersen5.   

Abstract

BACKGROUND: Small-conductance calcium-activated potassium (SK) channels have been found to play an important role in atrial repolarization and atrial fibrillation (AF).
OBJECTIVE: The purpose of this study was to investigate the existence and functional role of SK channels in the equine heart.
METHODS: Cardiac biopsies were analyzed to investigate the expression level of the most prominent cardiac ion channels, with special focus on SK channels, in the equine heart. Subcellular distribution of SK isoform 2 (SK2) was assessed by immunohistochemistry and confocal microscopy. The electrophysiologic and anti-AF effects of the relative selective SK channel inhibitor NS8593 (5 mg/kg IV) were evaluated in anesthetized horses, focusing on the potential of NS8593 to terminate acute pacing-induced AF, drug-induced changes in atrial effective refractory period, AF duration and vulnerability, and ventricular depolarization and repolarization times.
RESULTS: Analysis revealed equivalent mRNA transcript levels of the 3 SK channel isoforms in atria compared to ventricles. Immunohistochemistry and confocal microscopy displayed a widespread distribution of SK2 in both atrial and ventricular cardiomyocytes. NS8593 terminated all induced AF episodes (duration ≥15 minutes), caused pronounced prolongation of atrial effective refractory period, and reduced AF duration and vulnerability. QRS duration and QTc interval were not affected by treatment.
CONCLUSION: SK channels are widely distributed in atrial and ventricular cardiomyocytes and contribute to atrial repolarization. Inhibition by NS8593 terminates pacing-induced AF of short duration and decreases AF duration and vulnerability without affecting ventricular conduction and repolarization. Thus, inhibition by NS8593 demonstrates clear atrial antiarrhythmic properties in healthy horses.
Copyright © 2015 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antiarrhythmic drugs; Atrial electrophysiology; Atrial fibrillation; Equine; Horse; NS8593; Pacing; Programmed electrical stimulation; Reverse transcription polymerase chain reaction

Mesh:

Substances:

Year:  2014        PMID: 25542425     DOI: 10.1016/j.hrthm.2014.12.028

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  32 in total

1.  Endogenous and Agonist-induced Opening of Mitochondrial Big Versus Small Ca2+-sensitive K+ Channels on Cardiac Cell and Mitochondrial Protection.

Authors:  David F Stowe; Meiying Yang; James S Heisner; Amadou K S Camara
Journal:  J Cardiovasc Pharmacol       Date:  2017-11       Impact factor: 3.105

Review 2.  Pharmacological gating modulation of small- and intermediate-conductance Ca(2+)-activated K(+) channels (KCa2.x and KCa3.1).

Authors:  Palle Christophersen; Heike Wulff
Journal:  Channels (Austin)       Date:  2015-07-28       Impact factor: 2.581

3.  Impact of ISK Voltage and Ca2+/Mg2+-Dependent Rectification on Cardiac Repolarization.

Authors:  Peter Bronk; Tae Yun Kim; Iuliia Polina; Shanna Hamilton; Radmila Terentyeva; Karim Roder; Gideon Koren; Dmitry Terentyev; Bum-Rak Choi
Journal:  Biophys J       Date:  2020-06-27       Impact factor: 4.033

Review 4.  Genotype influence in responses to therapy for atrial fibrillation.

Authors:  Henry Huang; Dawood Darbar
Journal:  Expert Rev Cardiovasc Ther       Date:  2016-07-15

5.  Pharmacological blockade of small conductance Ca2+-activated K+ channels by ICA reduces arrhythmic load in rats with acute myocardial infarction.

Authors:  Laura A Hundahl; Stefan M Sattler; Lasse Skibsbye; Jonas G Diness; Jacob Tfelt-Hansen; Thomas Jespersen
Journal:  Pflugers Arch       Date:  2017-03-11       Impact factor: 3.657

6.  F-box protein-32 down-regulates small-conductance calcium-activated potassium channel 2 in diabetic mouse atria.

Authors:  Tian-You Ling; Fu Yi; Tong Lu; Xiao-Li Wang; Xiaojing Sun; Monte S Willis; Li-Qun Wu; Win-Kuang Shen; John P Adelman; Hon-Chi Lee
Journal:  J Biol Chem       Date:  2019-01-11       Impact factor: 5.157

7.  A new negative allosteric modulator, AP14145, for the study of small conductance calcium-activated potassium (KCa 2) channels.

Authors:  Rafel Simó-Vicens; Jeppe E Kirchhoff; Bernardo Dolce; Lea Abildgaard; Tobias Speerschneider; Ulrik S Sørensen; Morten Grunnet; Jonas G Diness; Bo H Bentzen
Journal:  Br J Pharmacol       Date:  2017-10-22       Impact factor: 8.739

8.  Effect of selective IK,ACh inhibition by XAF-1407 in an equine model of tachypacing-induced persistent atrial fibrillation.

Authors:  Merle Friederike Fenner; Helena Carstensen; Sarah Dalgas Nissen; Eva Melis Hesselkilde; Christine Scott Lunddahl; Maja Adler Hess Jensen; Ameli Victoria Loft-Andersen; Stefan Michael Sattler; Pyotr Platonov; Said El-Haou; Claire Jackson; Raymond Tang; Robert Kirby; John Ford; Ulrich Schotten; James Milnes; Ulrik Svane Sørensen; Thomas Jespersen; Rikke Buhl
Journal:  Br J Pharmacol       Date:  2020-06-24       Impact factor: 8.739

Review 9.  The regulation of the small-conductance calcium-activated potassium current and the mechanisms of sex dimorphism in J wave syndrome.

Authors:  Mu Chen; Yudong Fei; Tai-Zhong Chen; Yi-Gang Li; Peng-Sheng Chen
Journal:  Pflugers Arch       Date:  2021-01-07       Impact factor: 3.657

10.  The Natural Flavone Acacetin Blocks Small Conductance Ca2+-Activated K+ Channels Stably Expressed in HEK 293 Cells.

Authors:  Kui-Hao Chen; Hui Liu; Hai-Ying Sun; Man-Wen Jin; Guo-Sheng Xiao; Yan Wang; Gui-Rong Li
Journal:  Front Pharmacol       Date:  2017-10-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.